Lei Bao Selected Research

rubyrin

12/2013

Cell-specific and pH-activatable rubyrin-loaded nanoparticles for highly selective near-infrared photodynamic therapy against cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lei Bao Research Topics

Disease

43	Neoplasms (Cancer) 01/2022 - 04/2002
21	Inflammation (Inflammations) 11/2022 - 07/2005
11	Breast Neoplasms (Breast Cancer) 01/2021 - 08/2012
9	Atopic Dermatitis (Atopic Eczema) 12/2021 - 02/2012
8	Infections 01/2022 - 10/2006
8	Hypoxia (Hypoxemia) 01/2021 - 12/2014
7	Neuroblastoma 01/2022 - 10/2008
6	Pneumonia (Pneumonitis) 07/2020 - 01/2015
6	Silicosis 04/2020 - 07/2016
6	Type 2 Diabetes Mellitus (MODY) 12/2018 - 01/2013
6	Insulin Resistance 12/2018 - 01/2013
4	Bullous Pemphigoid (Pemphigoid) 11/2022 - 01/2021
4	Pulmonary Fibrosis (Fibrosing Alveolitis) 10/2022 - 07/2018
4	Mitochondrial Diseases (Mitochondrial Disease) 01/2022 - 08/2014
4	Wounds and Injuries (Trauma) 12/2021 - 12/2008
4	Neoplasm Metastasis (Metastasis) 01/2021 - 11/2011
4	COVID-19 01/2021 - 01/2020
4	Atherosclerosis 09/2020 - 11/2015
4	Leukemia 01/2020 - 03/2013
4	Uterine Cervical Neoplasms (Cancer of the Cervix) 11/2019 - 06/2005
4	Cerebral Hemorrhage 01/2017 - 01/2015
4	Reperfusion Injury 04/2015 - 12/2009
4	Experimental Autoimmune Neuritis 08/2004 - 10/2002
3	Psoriasis (Pustulosis Palmaris et Plantaris) 11/2022 - 01/2017
3	Glioblastoma (Glioblastoma Multiforme) 01/2022 - 09/2011
3	Stroke (Strokes) 09/2020 - 10/2016
3	Body Weight (Weight, Body) 01/2020 - 08/2014
3	Ductal Carcinoma 04/2015 - 03/2013
2	Diabetes Mellitus 11/2022 - 11/2015
2	Burns 11/2022 - 12/2008
2	Carcinoma (Carcinomatosis) 01/2022 - 05/2006
2	Hepatocellular Carcinoma (Hepatoma) 10/2021 - 01/2021
2	Ischemic Stroke 05/2021 - 01/2017
2	Urinary Tract Infections (Urinary Tract Infection) 03/2021 - 10/2020
2	Respiratory Insufficiency (Respiratory Failure) 01/2021 - 05/2020
2	Hyperglycemia 01/2021 - 09/2016
2	Triple Negative Breast Neoplasms 01/2021 - 08/2012
2	Cerebral Infarction 09/2020 - 03/2019
2	Hemorrhage 05/2020 - 01/2017
2	Fibrosis (Cirrhosis) 04/2020 - 12/2017
2	Pain (Aches) 01/2020 - 03/2011
2	Arthritis (Polyarthritis) 01/2020 - 07/2005
2	Bronchopulmonary Dysplasia 07/2019 - 01/2015
2	Uterine Cervicitis (Cervicitis) 01/2019 - 05/2006

Drug/Important Bio-Agent (IBA)

17	Proteins (Proteins, Gene)FDA Link 11/2022 - 02/2003
12	CytokinesIBA 01/2022 - 01/2013
10	Pharmaceutical PreparationsIBA 09/2022 - 04/2002
10	Glucose (Dextrose)FDA LinkGeneric 12/2018 - 01/2013
9	Interleukin-4 (Interleukin 4)IBA 12/2021 - 02/2012
8	Biological ProductsIBA 11/2022 - 01/2009
8	MicroRNAs (MicroRNA)IBA 01/2022 - 07/2014
8	Therapeutic UsesIBA 03/2021 - 08/2014
7	Silicon Dioxide (Silica)FDA LinkGeneric 10/2022 - 09/2017
6	AntigensIBA 09/2020 - 02/2004
5	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022 - 12/2014
5	Biomarkers (Surrogate Marker)IBA 01/2022 - 07/2014
5	AntioxidantsIBA 01/2022 - 01/2015
5	Messenger RNA (mRNA)IBA 01/2021 - 05/2006
5	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 08/2012
4	AutoantibodiesIBA 11/2022 - 09/2017
4	Ion Channels (Ion Channel)IBA 01/2022 - 12/2014
4	Long Noncoding RNAIBA 01/2021 - 07/2014
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2021 - 02/2003
4	Caspase 3 (Caspase-3)IBA 03/2019 - 02/2012
4	Hormones (Hormone)IBA 10/2015 - 03/2013
4	Peptides (Polypeptides)IBA 04/2012 - 09/2002
3	Complement System Proteins (Complement)IBA 11/2022 - 01/2021
3	Adenosine Triphosphate (ATP)IBA 01/2022 - 10/2015
3	Immunoglobulin G (IgG)IBA 01/2022 - 07/2005
3	AntibodiesIBA 01/2022 - 01/2021
3	Polysaccharides (Glycans)IBA 03/2021 - 06/2015
3	EnzymesIBA 01/2021 - 12/2016
3	Interleukin-10 (Interleukin 10)IBA 04/2020 - 02/2004
3	Interleukin-6 (Interleukin 6)IBA 04/2020 - 05/2007
3	RNA Polymerase II (RNA Polymerase B)IBA 01/2020 - 01/2018
3	CalciumIBA 01/2020 - 12/2014
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2019 - 09/2014
3	Glucosamine (Dona)IBA 02/2017 - 01/2015
3	Thrombin FDA Link 01/2017 - 05/2015
3	InterferonsIBA 08/2015 - 06/2011
3	Decitabine FDA Link 06/2014 - 06/2011
2	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2022 - 03/2021
2	NucleotidesIBA 01/2022 - 06/2016
2	RNA (Ribonucleic Acid)IBA 01/2021 - 03/2015
2	diacereinIBA 01/2021 - 01/2017
2	Glutamic Acid (Glutamate)FDA Link 01/2021 - 10/2016
2	VimentinIBA 01/2021 - 01/2019
2	Hypoxia-Inducible Factor 1IBA 01/2021 - 01/2018
2	Protein Isoforms (Isoforms)IBA 01/2021 - 12/2014
2	Photosensitizing Agents (Photosensitizers)IBA 06/2020 - 12/2013
2	NanocapsulesIBA 04/2020 - 01/2018
2	CC ChemokinesIBA 01/2020 - 07/2005
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2019 - 10/2008

Therapy/Procedure

16	Therapeutics 08/2021 - 04/2002
5	Drug Therapy (Chemotherapy) 01/2021 - 06/2005
4	Glycemic Control 01/2021 - 01/2016
4	Chinese Traditional Medicine (Traditional Chinese Medicine) 07/2020 - 01/2020
4	Aftercare (After-Treatment) 01/2020 - 08/2012
3	Immunotherapy 01/2021 - 09/2011
2	Transplantation 01/2021 - 03/2015